We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$11.4B
AUM Growth
-$318M
Cap. Flow
+$3.49M
Cap. Flow %
0.03%
Top 10 Hldgs %
29.99%
Holding
100
New
2
Increased
15
Reduced
62
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.8M
2
GSK icon
GSK
GSK
+$48.1M
3
TECK icon
Teck Resources
TECK
+$21.6M
4
AVNS
Avanos Medical
AVNS
+$6.39M
5
CVE icon
Cenovus Energy
CVE
+$4.92M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$37M
2
TLM
TALISMAN ENERGY INC
TLM
+$12.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.3M
4
TRI icon
Thomson Reuters
TRI
+$8.19M
5
SLF icon
Sun Life Financial
SLF
+$6.7M

Sector Composition

Rank Sector Weight
1 Financials 22.78%
2 Energy 19.58%
3 Communication Services 12.9%
4 Technology 8.07%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLAB icon
76
Photronics
PLAB
$1.89B
$11.6M 0.1%
1,397,445
-55,735
-4% -$477K
WX
77
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$8.42M 0.07%
250,000
– –
AVNS
78
DELISTED
Avanos Medical
AVNS
$7.39M 0.06%
+162,551
New +$6.39M
EQNR icon
79
Equinor
EQNR
$91.8B
$7.31M 0.06%
415,279
-1,459
-0.4% -$31.1K
CBPO
80
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$6.51M 0.06%
96,900
– –
MR
81
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$6.13M 0.05%
232,000
– –
IFN
82
Aberdeen India Fund
IFN
$505M
$5.86M 0.05%
226,945
– –
MBT
83
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$5.81M 0.05%
809,100
-200
-0% -$2.4K
ING icon
84
ING
ING
$103B
$4.3M 0.04%
331,386
-9,875
-3% -$137K
CMCSA icon
85
Comcast
CMCSA
$86.9B
$3.77M 0.03%
129,834
-300
-0.2% -$8.22K
EFA icon
86
iShares MSCI EAFE ETF
EFA
$79.5B
$2.93M 0.03%
48,125
-5,050
-9% -$315K
GGB icon
87
Gerdau
GGB
$9.99B
$2.82M 0.02%
1,002,456
– –
SPY icon
88
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$2.41M 0.02%
11,735
+275
+2% +$55.3K
RDS.B
89
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$917K 0.01%
13,187
-150
-1% -$10.8K
B
90
Barrick Mining
B
$68.3B
$653K 0.01%
60,500
– –
CCM
91
Concord Medical Services
CCM
$21.8M
$641K 0.01%
10,000
– –
MET icon
92
MetLife
MET
$61.8B
$544K ﹤0.01%
11,275
– –
TTE icon
93
TotalEnergies
TTE
$189B
$470K ﹤0.01%
5,821,008,840
– –
TEF
94
DELISTED
Telefonica
TEF
$427K ﹤0.01%
39,768
-1,137
-3% -$12.7K
EWU icon
95
iShares MSCI United Kingdom ETF
EWU
$4.14B
$382K ﹤0.01%
+10,600
New +$396K
TFX icon
96
Teleflex
TFX
$6.16B
$276K ﹤0.01%
2,404
– –
XOM icon
97
ExxonMobil
XOM
$630B
$230K ﹤0.01%
2,490
– –
EXAR
98
DELISTED
Exar Corporation
EXAR
$146K ﹤0.01%
14,281
– –
AZN icon
99
AstraZeneca
AZN
$251B
– –
-518,105
Closed -$37M
CP icon
100
Canadian Pacific Kansas City
CP
$80.6B
– –
-102,100
Closed -$4.24M
1 2 3
4

Similar funds

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
EIP
Energy Income Partners Westport, Connecticut $6.22B AUM 18.97% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.27B AUM 14.78% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Letko, Brosseau & Associates held 100 positions worth $11.4B, down 2.7% from $11.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 4%. Letko, Brosseau & Associates opened 2 new positions and exited 2, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q4 2014 buy was Avanos Medical: 162,551 shares worth $7.39M.
  • Letko, Brosseau & Associates added most to Gilead Sciences in Q4 2014, an estimated $61.8M increase.
  • Letko, Brosseau & Associates's biggest Q4 2014 reduction was TALISMAN ENERGY INC, cutting an estimated $12.4M.
  • Letko, Brosseau & Associates fully exited AstraZeneca in Q4 2014, selling an estimated $37M.
  • Letko, Brosseau & Associates's ten largest holdings make up 30% of its $11.4B portfolio in Q4 2014.
  • Letko, Brosseau & Associates opened 2 new positions and closed 2 in Q4 2014.
  • Letko, Brosseau & Associates's portfolio value fell 2.7% quarter-over-quarter to $11.4B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2014, filed 10 Feb 2015.